filmov
tv
Pushing the Envelope with PCSK9-Twenty Years of Progress
Показать описание
Michael D. Shapiro, DO
Wake Forest University, Cardiology
Wake Forest University, Cardiology
0:58:49
Pushing the Envelope with PCSK9-Twenty Years of Progress
1:06:38
Pushing the Envelope With PCSK9 and Beyond: 20 Years in Progress
0:05:41
What is PCSK9 and how PCSK9 inhibitors work? (Mechanism of action)
0:52:04
A Real World Approach to LDL cholesterol using PCSK9 inhibitors, October 5 2018
0:00:57
Who not start everyone on PCSK9 inhibitors since they work as well as statins? #pcsk9 #statin #chole
0:23:18
Professor Kausik Ray - PCSK9 inhibition – have we reached the limits of lipid lowering and outcome?...
0:01:47
Pharmacological Strategies beyond Statins: Ezetimibe and PCSK9 Inhibitors
0:03:11
NADIR ALI F | PSK9 Inhibitors TRIAL: cuts LDL by 60%, but RAISES MORTALITY!!
1:04:56
Intertwined Roles of PCSK9 in Lipoprotein Metabolism and Inflammation - Weekly Research Conference
0:11:16
Clinical Outcomes With PCSK9 Inhibitors
0:53:18
MSBI DOM Grand Rounds- Dr. Benjamin Hirsh
1:38:23
CVD risks and lipid management Webinar
0:28:11
Dr Peter Libby - Cardiac atheroma at the limits – are we fighting the final battle?
0:35:05
The Latest Science To Extend Lifespan
1:04:46
Anti-Thrombosis and Stenting (ROXANA MEHRAN, MD) May 3, 2018 - LIVESTREAM RECORDING
1:10:22
What Are The Treatment Options Of PAD? | Treating PAD
0:10:53
Combo of bad cholesterol and high blood pressure may increase heart attack or stroke risk
0:58:12
Super Genes: Do Exceptional Athletes Hold the Key to Health?
0:47:51
David Liu: A Master Class on the Future of Genome Editing
0:17:10
Antiplatelet Therapy: Where Do We Stand Now?
0:44:29
Parallax | Ep 59 - AHA Edition: 3 Trials that will change your practice with Dr Amit Khera
1:10:00
Regressing Atherosclerosis in Diabetes: Insights into Why This is Hard to Achieve
0:54:02
Lipoprotein(a): Who should be tested and why?
0:55:53
There Is Urgent Need to Treat Atherosclerotic Cardiovascular Disease
Комментарии